Ironwood Pharmaceuticals, Inc.
IRWD
$3.25
-$0.12-3.56%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.28M | 40.08M | 23.60M | -37.39M | 2.26M |
| Total Depreciation and Amortization | 460.00K | 475.00K | 467.00K | 479.00K | 485.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.93M | 32.24M | 19.55M | 6.79M | 46.49M |
| Change in Net Operating Assets | 73.46M | -25.21M | -58.68M | 50.08M | -34.01M |
| Cash from Operations | 74.58M | 47.58M | -15.07M | 19.95M | 15.21M |
| Capital Expenditure | 1.00K | -2.00K | -2.00K | -31.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1.00K | -2.00K | -2.00K | -31.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -15.00M |
| Issuance of Common Stock | 122.00K | 0.00 | 88.00K | 6.00K | 203.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -90.00K |
| Cash from Financing | 122.00K | 0.00 | 88.00K | 6.00K | -14.89M |
| Foreign Exchange rate Adjustments | 351.00K | -26.00K | -647.00K | -7.00K | 21.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.05M | 47.56M | -15.63M | 19.92M | 348.00K |